Janus Henderson Group
CRBU icon

Janus Henderson Group’s Caribou Biosciences CRBU Stock Holding History

Janus Henderson Group’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-25,333
Closed -$135K – 2610
2023
Q1 		$135K Buy
25,333
+11,655
+85% +$72.6K ﹤0.01% 2578
2022
Q4 		$86K Sell
13,678
-13,676
-50% -$122K ﹤0.01% 2359
2022
Q3 		$288K Buy
27,354
+13,615
+99% +$127K ﹤0.01% 2232
2022
Q2 		$75K Sell
13,739
-123,063
-90% -$941K ﹤0.01% 2513
2022
Q1 		$1.25M Sell
136,802
-1,035,923
-88% -$10.9M ﹤0.01% 1405
2021
Q4 		$16.7M Sell
1,172,725
-66,927
-5% -$1.3M 0.01% 829
2021
Q3 		$28.5M Buy
+1,239,652
New +$30.3M 0.01% 706

Other funds holding CRBU

PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Janus Henderson Group's CRBU Position: Q2 2023 in Review

Janus Henderson Group sold out of Caribou Biosciences (CRBU) in Q2 2023, closing a stake of 25,333 shares — an estimated $135K sold.

Janus Henderson Group first reported a position in CRBU in Q3 2021 and held it in 7 quarters. The position peaked at $28.5M in Q3 2021. 121 funds tracked by Wall St. Rank hold CRBU as of Q2 2023.

  • Janus Henderson Group reported no remaining Caribou Biosciences position as of Q2 2023 after selling out during the quarter.
  • Janus Henderson Group sold 25,333 Caribou Biosciences shares in Q2 2023, an estimated $135K.
  • Janus Henderson Group first reported a position in Caribou Biosciences in Q3 2021 and held it in 7 quarters.
  • Janus Henderson Group's Caribou Biosciences position peaked at $28.5M in Q3 2021.
  • 121 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2023.

Based on Janus Henderson Group's 13F filing for Q2 2023, filed 14 Aug 2023.